CBFB is an inclusion eligibility criterion in 1 clinical trial for core binding factor acute myeloid leukemia, of which 1 is open and 0 are closed. Of the trial that contains CBFB status and core binding factor acute myeloid leukemia as inclusion criteria, 1 is phase 3 (1 open) [3].

MYH11 is an inclusion eligibility criterion in 1 clinical trial for core binding factor acute myeloid leukemia, of which 1 is open and 0 are closed. Of the trial that contains MYH11 status and core binding factor acute myeloid leukemia as inclusion criteria, 1 is phase 3 (1 open) [3].

RUNX1 is an inclusion eligibility criterion in 1 clinical trial for core binding factor acute myeloid leukemia, of which 1 is open and 0 are closed. Of the trial that contains RUNX1 status and core binding factor acute myeloid leukemia as inclusion criteria, 1 is phase 3 (1 open) [3].

RUNX1T1 is an inclusion eligibility criterion in 1 clinical trial for core binding factor acute myeloid leukemia, of which 1 is open and 0 are closed. Of the trial that contains RUNX1T1 status and core binding factor acute myeloid leukemia as inclusion criteria, 1 is phase 3 (1 open) [3].